FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893533072> ?p ?o ?g. }

• W2893533072 endingPage "S12" @default.
• W2893533072 startingPage "S11" @default.
• W2893533072 abstract "Among patients with myocardial infarction (MI), higher potency ADP receptor inhibitors (ADPri) (e.g. ticagrelor) are associated with greater reduction in events compared with clopidogrel. The ongoing ACS Reflective II, an observational, quality enhancement research initiative was initiated to identify moderate to high-risk non-ST elevation MI (NSTEMI) patients who do and do not receive guideline-recommended dual antiplatelet therapy (DAPT) and potential reasons why not. Cardiologists enrolled patients 18 years presenting with moderate-to-high risk NSTEMI. Demographic, presentation and treatment data was captured through a standardized data collection form (DCF). Since September 2016, 512 patients have been enrolled by 52 cardiologists in 13 hospitals across Canada. The median (25th, 75th percentile) age is 68 (60, 75) years, 70% are male, 36% have diabetes, 8% have atrial fibrillation (AF), and 5% had prior stroke. Coronary angiography was performed in 85%; 63% were treated with percutaneous coronary intervention (PCI) and 18% underwent coronary artery bypass grafting (CABG). In the first 24 hours of hospitalization, 98% received aspirin and 92% received an ADPri (54% ticagrelor, 1% prasugrel, 43% clopidogrel). The most common reasons (not mutually exclusive) for not receiving ticagrelor in the first 24 hours included physician preference (31%), perceived high risk for bleeding (25%) and plan for coronary artery bypass grafting (CABG) (15%) (Figure 1). Three in-hospital deaths were observed. At the time of hospital discharge, 97% of the patients were on aspirin, 79% received an ADPri (46% ticagrelor, 1% prasugrel, 33% clopidogrel), and 11% an oral anticoagulant (OAC), including 9% on a non-vitamin K antagonist (NOAC). The most common reasons for not receiving ticagrelor at discharge (not mutually exclusive) included physician preference (28%), perceived high risk for bleeding (28%) and need for OAC (14%) (Figure 1). Among patients discharged on clopidogrel, 13% had atrial fibrillation, 18% were treated with oral anticoagulant, and 8% had prior stroke (Table 1). In contemporary Canadian practice, approximately one third of moderate to high-risk NSTEMI patients are still treated acutely in hospital and on discharge with clopidogrel. Physician preference for clopidogrel and avoidance of bleeding in the setting of advanced age are the most frequently cited reasons for avoiding ticagrelor. Only a minority of patients discharged on clopidogrel have an absolute or relative contraindication to higher potency ADPri. Opportunities remain for further optimization of evidence-based, guideline-recommended antiplatelet therapy use in NSTEMI patients in Canada.View Large Image Figure ViewerDownload Hi-res image Download (PPT)" @default.
• W2893533072 created "2018-10-05" @default.
• W2893533072 creator A5005137768 @default.
• W2893533072 creator A5010276541 @default.
• W2893533072 creator A5016160940 @default.
• W2893533072 creator A5017666786 @default.
• W2893533072 creator A5042070219 @default.
• W2893533072 creator A5047187243 @default.
• W2893533072 creator A5056667853 @default.
• W2893533072 creator A5062599106 @default.
• W2893533072 creator A5064482802 @default.
• W2893533072 creator A5067998107 @default.
• W2893533072 creator A5070050361 @default.
• W2893533072 creator A5070593574 @default.
• W2893533072 creator A5072521028 @default.
• W2893533072 creator A5073272747 @default.
• W2893533072 creator A5079301231 @default.
• W2893533072 creator A5082802722 @default.
• W2893533072 creator A5083162965 @default.
• W2893533072 creator A5084015464 @default.
• W2893533072 creator A5085975703 @default.
• W2893533072 creator A5090299888 @default.
• W2893533072 creator A5021557791 @default.
• W2893533072 date "2018-10-01" @default.
• W2893533072 modified "2023-09-27" @default.
• W2893533072 title "CONTEMPORARY ANTIPLATELET THERAPY IN MODERATE TO HIGH-RISK PATIENTS WITH NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE CANADIAN ACS REFLECTIVE II STUDY" @default.
• W2893533072 doi "https://doi.org/10.1016/j.cjca.2018.07.391" @default.
• W2893533072 hasPublicationYear "2018" @default.
• W2893533072 type Work @default.
• W2893533072 sameAs 2893533072 @default.
• W2893533072 citedByCount "0" @default.
• W2893533072 crossrefType "journal-article" @default.
• W2893533072 hasAuthorship W2893533072A5005137768 @default.
• W2893533072 hasAuthorship W2893533072A5010276541 @default.
• W2893533072 hasAuthorship W2893533072A5016160940 @default.
• W2893533072 hasAuthorship W2893533072A5017666786 @default.
• W2893533072 hasAuthorship W2893533072A5021557791 @default.
• W2893533072 hasAuthorship W2893533072A5042070219 @default.
• W2893533072 hasAuthorship W2893533072A5047187243 @default.
• W2893533072 hasAuthorship W2893533072A5056667853 @default.
• W2893533072 hasAuthorship W2893533072A5062599106 @default.
• W2893533072 hasAuthorship W2893533072A5064482802 @default.
• W2893533072 hasAuthorship W2893533072A5067998107 @default.
• W2893533072 hasAuthorship W2893533072A5070050361 @default.
• W2893533072 hasAuthorship W2893533072A5070593574 @default.
• W2893533072 hasAuthorship W2893533072A5072521028 @default.
• W2893533072 hasAuthorship W2893533072A5073272747 @default.
• W2893533072 hasAuthorship W2893533072A5079301231 @default.
• W2893533072 hasAuthorship W2893533072A5082802722 @default.
• W2893533072 hasAuthorship W2893533072A5083162965 @default.
• W2893533072 hasAuthorship W2893533072A5084015464 @default.
• W2893533072 hasAuthorship W2893533072A5085975703 @default.
• W2893533072 hasAuthorship W2893533072A5090299888 @default.
• W2893533072 hasBestOaLocation W28935330721 @default.
• W2893533072 hasConcept C126322002 @default.
• W2893533072 hasConcept C127413603 @default.
• W2893533072 hasConcept C164705383 @default.
• W2893533072 hasConcept C2777028646 @default.
• W2893533072 hasConcept C2777628954 @default.
• W2893533072 hasConcept C2777698277 @default.
• W2893533072 hasConcept C2777849778 @default.
• W2893533072 hasConcept C2777995511 @default.
• W2893533072 hasConcept C2779161974 @default.
• W2893533072 hasConcept C2780400711 @default.
• W2893533072 hasConcept C2780645631 @default.
• W2893533072 hasConcept C2780890252 @default.
• W2893533072 hasConcept C500558357 @default.
• W2893533072 hasConcept C71924100 @default.
• W2893533072 hasConcept C78519656 @default.
• W2893533072 hasConceptScore W2893533072C126322002 @default.
• W2893533072 hasConceptScore W2893533072C127413603 @default.
• W2893533072 hasConceptScore W2893533072C164705383 @default.
• W2893533072 hasConceptScore W2893533072C2777028646 @default.
• W2893533072 hasConceptScore W2893533072C2777628954 @default.
• W2893533072 hasConceptScore W2893533072C2777698277 @default.
• W2893533072 hasConceptScore W2893533072C2777849778 @default.
• W2893533072 hasConceptScore W2893533072C2777995511 @default.
• W2893533072 hasConceptScore W2893533072C2779161974 @default.
• W2893533072 hasConceptScore W2893533072C2780400711 @default.
• W2893533072 hasConceptScore W2893533072C2780645631 @default.
• W2893533072 hasConceptScore W2893533072C2780890252 @default.
• W2893533072 hasConceptScore W2893533072C500558357 @default.
• W2893533072 hasConceptScore W2893533072C71924100 @default.
• W2893533072 hasConceptScore W2893533072C78519656 @default.
• W2893533072 hasIssue "10" @default.
• W2893533072 hasLocation W28935330721 @default.
• W2893533072 hasOpenAccess W2893533072 @default.
• W2893533072 hasPrimaryLocation W28935330721 @default.
• W2893533072 hasRelatedWork W2127122046 @default.
• W2893533072 hasRelatedWork W2316757300 @default.
• W2893533072 hasRelatedWork W2366835925 @default.
• W2893533072 hasRelatedWork W2566822712 @default.
• W2893533072 hasRelatedWork W2775269597 @default.
• W2893533072 hasRelatedWork W2799418283 @default.
• W2893533072 hasRelatedWork W3134665543 @default.
• W2893533072 hasRelatedWork W3207761463 @default.
• W2893533072 hasRelatedWork W4235077280 @default.
• W2893533072 hasRelatedWork W4290840724 @default.

• next